Review of 2022 PSOGI/RENAPE Consensus on HIPEC

Shigeki Kusamura¹, Aditi Bhatt², Kurt van Der Speeten³, Vahan Kepenekian^{4

5}, Martin Hübner⁶, Clarisse Eveno⁷, Ignace de Hingh⁸, Jean-Baptiste Delhorme⁹, Abdelkader Taibi^{10

11}, Laurent Villeneuve¹², Rea Lo Dico¹³, Brendan Moran¹⁴, Kim Govaerts³, Oliver Zivanovic¹⁵, Donal Brennan¹⁶, Cedric Nadeau¹⁷, Willemien Van Driel¹⁸, Naoual Bakrin¹⁹, Pompiliu Piso²⁰, Victor J Verwaal²¹, Santiago González-Moreno²², Mohammad Alyami²³, Olivia Sgarbura²⁴, Beate Rau²⁵, Marcello Deraco¹, Olivier Glehen^{4

5}

Affiliations

¹ PSM Unit, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Surgical Oncology, KD Hospital, Ahmedabad, India.
³ Department of Abdominal and Oncological Surgery, Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.
⁴ Department of Oncological Surgery, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
⁵ CICLY, Université Claude Bernard Lyon 1, Lyon, France.
⁶ Department of Visceral Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
⁷ Department of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, Lille, France.
⁸ Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
⁹ Department of General and Digestive Surgery, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
¹⁰ Department of Digestive Surgery, Dupuytren University Hospital, Limoges, France.
¹¹ XLIM, UMR 7252, CNRS, Limoges, France.
¹² Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Recherche et d'Epidémiologie Cliniques, Pierre-Bénite, France.
¹³ Department of General Surgery, Emergency, and New Technologies, San Camillo Forlanini Hospital, Rome, Italy.
¹⁴ Peritoneal Malignancy Unit, Basingstoke Hospital, Basingstoke, UK.
¹⁵ Department of Gynecological Oncology, Heidelberg Medizinische Klinik, Heidelberg, Germany.
¹⁶ UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
¹⁷ Department of Gynecological Oncology, Clinique du Fief de Grimoire, Poitiers, Cedex, France.
¹⁸ Department of Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁹ Department of Surgical Oncology, Hôpita Lyon Sud, Hospices Civils de Lyon, Lyon, France.
²⁰ Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany.
²¹ Peritoneal Surface Malignancy and HIPEC Skåne University Hospital, Lunds University Sweden, Lunds, Sweden.
²² MD Anderson Cancer Center, Madrid, Spain.
²³ Department of General Surgery and Surgical Oncology, King Khalid Hospital, Najran, Saudi Arabia.
²⁴ Department of Surgical Oncology, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
²⁵ Chirurgische Klinik, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin, Germany.

PMID: 39285659
PMCID: PMC11826010
DOI: 10.1002/jso.27885

Review

Review of 2022 PSOGI/RENAPE Consensus on HIPEC

Shigeki Kusamura et al. J Surg Oncol. 2024 Nov.

. 2024 Nov;130(6):1290-1298.

doi: 10.1002/jso.27885. Epub 2024 Sep 16.

Authors

Affiliations

¹ PSM Unit, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Surgical Oncology, KD Hospital, Ahmedabad, India.
³ Department of Abdominal and Oncological Surgery, Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.
⁴ Department of Oncological Surgery, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
⁵ CICLY, Université Claude Bernard Lyon 1, Lyon, France.
⁶ Department of Visceral Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
⁷ Department of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, Lille, France.
⁸ Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
⁹ Department of General and Digestive Surgery, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
¹⁰ Department of Digestive Surgery, Dupuytren University Hospital, Limoges, France.
¹¹ XLIM, UMR 7252, CNRS, Limoges, France.
¹² Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Recherche et d'Epidémiologie Cliniques, Pierre-Bénite, France.
¹³ Department of General Surgery, Emergency, and New Technologies, San Camillo Forlanini Hospital, Rome, Italy.
¹⁴ Peritoneal Malignancy Unit, Basingstoke Hospital, Basingstoke, UK.
¹⁵ Department of Gynecological Oncology, Heidelberg Medizinische Klinik, Heidelberg, Germany.
¹⁶ UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
¹⁷ Department of Gynecological Oncology, Clinique du Fief de Grimoire, Poitiers, Cedex, France.
¹⁸ Department of Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁹ Department of Surgical Oncology, Hôpita Lyon Sud, Hospices Civils de Lyon, Lyon, France.
²⁰ Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany.
²¹ Peritoneal Surface Malignancy and HIPEC Skåne University Hospital, Lunds University Sweden, Lunds, Sweden.
²² MD Anderson Cancer Center, Madrid, Spain.
²³ Department of General Surgery and Surgical Oncology, King Khalid Hospital, Najran, Saudi Arabia.
²⁴ Department of Surgical Oncology, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
²⁵ Chirurgische Klinik, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin, Germany.

PMID: 39285659
PMCID: PMC11826010
DOI: 10.1002/jso.27885

Abstract

The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.

Keywords: HIPEC regimens; consensus; hyperthermic intraperitoneal chemotherapy; peritoneal surface malignancies.

PubMed Disclaimer

References

1. Yurttas C., Hoffmann G., Tolios A., et al., “Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis From Colorectal Cancer,” Journal of Clinical Medicine 7, no. 12 (December 19, 2018): 567. - PMC - PubMed
1. Bhatt A., Glehen O., Zivanovic O., et al., “The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer,” Annals of Surgical Oncology 30, no. 13 (December 2023): 8115–8137. - PubMed
1. Kusamura S., Delhorme J. B., Taibi A., et al., “The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma Peritonei,” Annals of Surgical Oncology 31, no. 9 (September 2024): 6262–6273. - PubMed
1. Hübner M., Van Der Speeten K., Govaerts K., et al., “2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer,” Annals of Surgical Oncology 31, no. 1 (January 2024): 567–576. - PMC - PubMed
1. Kepenekian V., Sgarbura O., Marchal F., Villeneuve L., Kusamura S., and Deraco M., “2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma,” Annals of Surgical Oncology 30, no. 12 (November 2023): 7803–7813. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Review of 2022 PSOGI/RENAPE Consensus on HIPEC

Affiliations

Review of 2022 PSOGI/RENAPE Consensus on HIPEC

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical